Skip to main content
logo
Ganga Pharmaceuticals Limited (BOM:539680)
India flag India · Delayed Price · Currency is INR
12.50
+0.50 (4.17%)
At close: Sep 8, 2026

Ganga Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
28.2128.2826.3727.3625.8624.89
Revenue Growth
-0.26%7.22%-3.60%5.78%3.91%4.83%
Gross Profit
14.115.1714.1814.8513.3811.97
Operating Income
-0.82-0.17-1.630.08-0.51-0.13
Net Income
0.651.020.790.470.390.38
Earnings Per Share
0.300.170.120.070.100.09
EPS Growth
76.47%41.67%71.43%-27.67%7.53%80.00%

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.220.583.020.30.290.2
Total Debt
12.2610.914.2113.5818.2619.28
Net Cash (Debt)
-12.04-10.32-11.19-13.28-17.97-19.07
Net Cash Growth
------
Net Cash Per Share
-5.64-1.75-1.69-2.01-4.43-4.70

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-5.29-13.11-5.77-12.64-0.4-2.11
Capital Expenditures
-0.28-0.37-0.99-0.22-0.15-0.15
Free Cash Flow
-5.57-13.48-6.76-12.86-0.55-2.25
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
49.97%53.65%53.77%54.29%51.73%48.10%
Operating Margin
-2.89%-0.59%-6.17%0.31%-1.99%-0.51%
Pretax Margin
3.22%4.57%3.59%2.31%2.05%2.06%
Profit Margin
2.31%3.59%3.00%1.70%1.52%1.52%
FCF Margin
-19.74%-47.65%-25.63%-47.02%-2.11%-9.06%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
41.6769.8962.26253.25143.94109.87
PS Ratio
2.622.511.874.322.191.67